These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10584915)

  • 21. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-assisted treatment with methadone: assessing the evidence.
    Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain Management in the Opioid-Dependent Pregnant Woman.
    Safley RR; Swietlikowski J
    J Perinat Neonatal Nurs; 2017; 31(2):118-125. PubMed ID: 28437302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
    Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
    Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
    Holbrook AM
    Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
    Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
    Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
    Martin PR; Finlayson AJ
    Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Stitzer ML
    Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
    [No Abstract]   [Full Text] [Related]  

  • 34. Maternal and neonatal outcomes following methadone substitution during pregnancy.
    Greig E; Ash A; Douiri A
    Arch Gynecol Obstet; 2012 Oct; 286(4):843-51. PubMed ID: 22584603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance agonist treatments for opiate dependent pregnant women.
    Minozzi S; Amato L; Vecchi S; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006318. PubMed ID: 18425946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Opiate dependent pregnant patients and mothers. What must be regarded in drug substitution and detoxification].
    Schwejda C; Bystron C; Federmann M; Schmidt J; Bussello-Spieth S; Tretter F
    MMW Fortschr Med; 2001 May; 143 Suppl 2():84-6. PubMed ID: 11434268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?
    Hensley L; Sulo S; Kozmic S; Parilla BV
    J Addict Med; 2018; 12(1):61-64. PubMed ID: 29068826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic and acute pain and pain management for patients in methadone maintenance treatment.
    Eyler EC
    Am J Addict; 2013 Jan; 22(1):75-83. PubMed ID: 23398230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.